In a study investigating gastric cancer peritoneal metastases, blockade of the C3-C3AR1 axis was shown to disrupt stroma-myeloid crosstalk, leading to enhanced efficacy of immune checkpoint blockade (ICB) in preclinical models. The gene discussed is C3AR1; the disease is gastric cancer.